These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Asthma and COPD management during the COVID-19 pandemic]. Daccord C; Touilloux B; Von Garnier C Rev Med Suisse; 2020 May; 16(692):933-938. PubMed ID: 32374540 [TBL] [Abstract][Full Text] [Related]
5. Use of corticosteroids in asthma and COPD patients with or without COVID-19. Hasan SS; Capstick T; Zaidi STR; Kow CS; Merchant HA Respir Med; 2020; 170():106045. PubMed ID: 32843175 [TBL] [Abstract][Full Text] [Related]
6. Covid-19 and COPD: A Personal Reflection. Russell R Int J Chron Obstruct Pulmon Dis; 2020; 15():883-884. PubMed ID: 32425514 [No Abstract] [Full Text] [Related]
7. Severe asthma during the COVID-19 pandemic: Clinical observations. Haroun-Díaz E; Vázquez de la Torre M; Ruano FJ; Somoza Álvarez ML; Alzate DP; González PL; Prieto-Moreno A; Rojas IT; Cervera García MD; Blanca-López N; Díez GC J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2787-2789. PubMed ID: 32599217 [No Abstract] [Full Text] [Related]
8. Rate of Patient-Driven Biologic Treatment Discontinuation During the COVID-19 Pandemic in 2 Academic Hospital Clinics at the University of Toronto. Georgakopoulos JR; Yeung J J Cutan Med Surg; 2020; 24(4):424-425. PubMed ID: 32475151 [No Abstract] [Full Text] [Related]
9. COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection? McAlinden KD; Eapen MS; Lu W; Chia C; Haug G; Sohal SS Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32430427 [TBL] [Abstract][Full Text] [Related]
10. Patient-Driven Discontinuation of Dupilumab During the COVID-19 Pandemic in Two Academic Hospital Clinics at the University of Toronto. Georgakopoulos JR; Yeung J J Cutan Med Surg; 2020; 24(4):422-423. PubMed ID: 32434413 [No Abstract] [Full Text] [Related]
12. Impact of the COVID-19 pandemic in children with allergic asthma. Ruano FJ; Somoza Álvarez ML; Haroun-Díaz E; Vázquez de la Torre M; López González P; Prieto-Moreno A; Torres Rojas I; Cervera García MD; Pérez Alzate D; Blanca-López N; Canto Díez G J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3172-3174.e1. PubMed ID: 32730834 [No Abstract] [Full Text] [Related]
13. Patient-Driven Discontinuation of Apremilast During the COVID-19 Pandemic in Two Canadian Academic Hospital Clinics and One Community Practice. Georgakopoulos JR; Vender R; Yeung J J Cutan Med Surg; 2020; 24(4):418-419. PubMed ID: 32396018 [No Abstract] [Full Text] [Related]
14. Chronic obstructive pulmonary disease and the COVID-19 pandemic: Reciprocal challenges. Deslée G; Zysman M; Burgel PR; Perez T; Boyer L; Gonzalez J; Roche N; Respir Med Res; 2020 Nov; 78():100764. PubMed ID: 32498023 [No Abstract] [Full Text] [Related]
15. The Unexpected Risks of COVID-19 on Asthma Control in Children. Oreskovic NM; Kinane TB; Aryee E; Kuhlthau KA; Perrin JM J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2489-2491. PubMed ID: 32497662 [TBL] [Abstract][Full Text] [Related]
16. [The novel coronavirus covid-19 pandemic]. Cuestas E Rev Fac Cien Med Univ Nac Cordoba; 2020 Mar; 77(1):1-3. PubMed ID: 32238250 [No Abstract] [Full Text] [Related]
17. Reflecting on World Asthma Day in the era of COVID-19. The Lancet Respiratory Medicine Lancet Respir Med; 2020 May; 8(5):423. PubMed ID: 32334644 [No Abstract] [Full Text] [Related]
18. Chronic inflammatory skin diseases and biologics: what to expect after COVID-19 pandemic? Megna M; Fabbrocini G; Marasca C Int J Dermatol; 2020 Sep; 59(9):1144-1145. PubMed ID: 32710548 [No Abstract] [Full Text] [Related]